Table of Content

1 Montelukast Drug Market Overview
1.1 Product Overview and Scope of Montelukast Drug
1.2 Montelukast Drug Segment by Type
1.2.1 Global Montelukast Drug Market Value Comparison by Type (2024-2034)
1.2.2 Tablets
1.2.3 Oral Granules
1.3 Montelukast Drug Segment by Application
1.3.1 Global Montelukast Drug Market Value by Application: (2024-2034)
1.3.2 Hospital
1.3.3 Drug Store
1.3.4 Others
1.4 Global Montelukast Drug Market Size Estimates and Forecasts
1.4.1 Global Montelukast Drug Revenue 2018-2029
1.4.2 Global Montelukast Drug Sales 2018-2029
1.4.3 Global Montelukast Drug Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Montelukast Drug Market Competition by Manufacturers
2.1 Global Montelukast Drug Sales Market Share by Manufacturers (2018-2024)
2.2 Global Montelukast Drug Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Montelukast Drug Average Price by Manufacturers (2018-2024)
2.4 Global Montelukast Drug Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Montelukast Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Montelukast Drug, Product Type & Application
2.7 Montelukast Drug Market Competitive Situation and Trends
2.7.1 Montelukast Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Montelukast Drug Players Market Share by Revenue
2.7.3 Global Montelukast Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Montelukast Drug Retrospective Market Scenario by Region
3.1 Global Montelukast Drug Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Montelukast Drug Global Montelukast Drug Sales by Region: 2018-2029
3.2.1 Global Montelukast Drug Sales by Region: 2018-2024
3.2.2 Global Montelukast Drug Sales by Region: 2024-2029
3.3 Global Montelukast Drug Global Montelukast Drug Revenue by Region: 2018-2029
3.3.1 Global Montelukast Drug Revenue by Region: 2018-2024
3.3.2 Global Montelukast Drug Revenue by Region: 2024-2029
3.4 North America Montelukast Drug Market Facts & Figures by Country
3.4.1 North America Montelukast Drug Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Montelukast Drug Sales by Country (2018-2029)
3.4.3 North America Montelukast Drug Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Montelukast Drug Market Facts & Figures by Country
3.5.1 Europe Montelukast Drug Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Montelukast Drug Sales by Country (2018-2029)
3.5.3 Europe Montelukast Drug Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Montelukast Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Montelukast Drug Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Montelukast Drug Sales by Country (2018-2029)
3.6.3 Asia Pacific Montelukast Drug Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Montelukast Drug Market Facts & Figures by Country
3.7.1 Latin America Montelukast Drug Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Montelukast Drug Sales by Country (2018-2029)
3.7.3 Latin America Montelukast Drug Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Montelukast Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Montelukast Drug Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Montelukast Drug Sales by Country (2018-2029)
3.8.3 Middle East and Africa Montelukast Drug Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Montelukast Drug Sales by Type (2018-2029)
4.1.1 Global Montelukast Drug Sales by Type (2018-2024)
4.1.2 Global Montelukast Drug Sales by Type (2024-2029)
4.1.3 Global Montelukast Drug Sales Market Share by Type (2018-2029)
4.2 Global Montelukast Drug Revenue by Type (2018-2029)
4.2.1 Global Montelukast Drug Revenue by Type (2018-2024)
4.2.2 Global Montelukast Drug Revenue by Type (2024-2029)
4.2.3 Global Montelukast Drug Revenue Market Share by Type (2018-2029)
4.3 Global Montelukast Drug Price by Type (2018-2029)
5 Segment by Application
5.1 Global Montelukast Drug Sales by Application (2018-2029)
5.1.1 Global Montelukast Drug Sales by Application (2018-2024)
5.1.2 Global Montelukast Drug Sales by Application (2024-2029)
5.1.3 Global Montelukast Drug Sales Market Share by Application (2018-2029)
5.2 Global Montelukast Drug Revenue by Application (2018-2029)
5.2.1 Global Montelukast Drug Revenue by Application (2018-2024)
5.2.2 Global Montelukast Drug Revenue by Application (2024-2029)
5.2.3 Global Montelukast Drug Revenue Market Share by Application (2018-2029)
5.3 Global Montelukast Drug Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Merck & Co.
6.1.1 Merck & Co. Corporation Information
6.1.2 Merck & Co. Description and Business Overview
6.1.3 Merck & Co. Montelukast Drug Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Merck & Co. Montelukast Drug Product Portfolio
6.1.5 Merck & Co. Recent Developments/Updates
6.2 Teva
6.2.1 Teva Corporation Information
6.2.2 Teva Description and Business Overview
6.2.3 Teva Montelukast Drug Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Teva Montelukast Drug Product Portfolio
6.2.5 Teva Recent Developments/Updates
6.3 Mylan
6.3.1 Mylan Corporation Information
6.3.2 Mylan Description and Business Overview
6.3.3 Mylan Montelukast Drug Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Mylan Montelukast Drug Product Portfolio
6.3.5 Mylan Recent Developments/Updates
6.4 Glenmark Pharmaceuticals
6.4.1 Glenmark Pharmaceuticals Corporation Information
6.4.2 Glenmark Pharmaceuticals Description and Business Overview
6.4.3 Glenmark Pharmaceuticals Montelukast Drug Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Glenmark Pharmaceuticals Montelukast Drug Product Portfolio
6.4.5 Glenmark Pharmaceuticals Recent Developments/Updates
6.5 Hikma Group
6.5.1 Hikma Group Corporation Information
6.5.2 Hikma Group Description and Business Overview
6.5.3 Hikma Group Montelukast Drug Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Hikma Group Montelukast Drug Product Portfolio
6.5.5 Hikma Group Recent Developments/Updates
6.6 Sandoz
6.6.1 Sandoz Corporation Information
6.6.2 Sandoz Description and Business Overview
6.6.3 Sandoz Montelukast Drug Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Sandoz Montelukast Drug Product Portfolio
6.6.5 Sandoz Recent Developments/Updates
6.7 Torrent Pharmaceuticals
6.6.1 Torrent Pharmaceuticals Corporation Information
6.6.2 Torrent Pharmaceuticals Description and Business Overview
6.6.3 Torrent Pharmaceuticals Montelukast Drug Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Torrent Pharmaceuticals Montelukast Drug Product Portfolio
6.7.5 Torrent Pharmaceuticals Recent Developments/Updates
6.8 Lannett Company
6.8.1 Lannett Company Corporation Information
6.8.2 Lannett Company Description and Business Overview
6.8.3 Lannett Company Montelukast Drug Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Lannett Company Montelukast Drug Product Portfolio
6.8.5 Lannett Company Recent Developments/Updates
6.9 Apotex
6.9.1 Apotex Corporation Information
6.9.2 Apotex Description and Business Overview
6.9.3 Apotex Montelukast Drug Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Apotex Montelukast Drug Product Portfolio
6.9.5 Apotex Recent Developments/Updates
6.10 Dr. Reddys Laboratories
6.10.1 Dr. Reddys Laboratories Corporation Information
6.10.2 Dr. Reddys Laboratories Description and Business Overview
6.10.3 Dr. Reddys Laboratories Montelukast Drug Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Dr. Reddys Laboratories Montelukast Drug Product Portfolio
6.10.5 Dr. Reddys Laboratories Recent Developments/Updates
6.11 Aurobindo Pharma
6.11.1 Aurobindo Pharma Corporation Information
6.11.2 Aurobindo Pharma Montelukast Drug Description and Business Overview
6.11.3 Aurobindo Pharma Montelukast Drug Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Aurobindo Pharma Montelukast Drug Product Portfolio
6.11.5 Aurobindo Pharma Recent Developments/Updates
6.12 Accord Healthcare
6.12.1 Accord Healthcare Corporation Information
6.12.2 Accord Healthcare Montelukast Drug Description and Business Overview
6.12.3 Accord Healthcare Montelukast Drug Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Accord Healthcare Montelukast Drug Product Portfolio
6.12.5 Accord Healthcare Recent Developments/Updates
6.13 Hetero
6.13.1 Hetero Corporation Information
6.13.2 Hetero Montelukast Drug Description and Business Overview
6.13.3 Hetero Montelukast Drug Sales, Revenue and Gross Margin (2018-2024)
6.13.4 Hetero Montelukast Drug Product Portfolio
6.13.5 Hetero Recent Developments/Updates
6.14 Unimark
6.14.1 Unimark Corporation Information
6.14.2 Unimark Montelukast Drug Description and Business Overview
6.14.3 Unimark Montelukast Drug Sales, Revenue and Gross Margin (2018-2024)
6.14.4 Unimark Montelukast Drug Product Portfolio
6.14.5 Unimark Recent Developments/Updates
6.15 Ajanta Pharma
6.15.1 Ajanta Pharma Corporation Information
6.15.2 Ajanta Pharma Montelukast Drug Description and Business Overview
6.15.3 Ajanta Pharma Montelukast Drug Sales, Revenue and Gross Margin (2018-2024)
6.15.4 Ajanta Pharma Montelukast Drug Product Portfolio
6.15.5 Ajanta Pharma Recent Developments/Updates
6.16 MACLEODS
6.16.1 MACLEODS Corporation Information
6.16.2 MACLEODS Montelukast Drug Description and Business Overview
6.16.3 MACLEODS Montelukast Drug Sales, Revenue and Gross Margin (2018-2024)
6.16.4 MACLEODS Montelukast Drug Product Portfolio
6.16.5 MACLEODS Recent Developments/Updates
6.17 Jubilant Pharma
6.17.1 Jubilant Pharma Corporation Information
6.17.2 Jubilant Pharma Montelukast Drug Description and Business Overview
6.17.3 Jubilant Pharma Montelukast Drug Sales, Revenue and Gross Margin (2018-2024)
6.17.4 Jubilant Pharma Montelukast Drug Product Portfolio
6.17.5 Jubilant Pharma Recent Developments/Updates
6.18 Unichem Laboratories
6.18.1 Unichem Laboratories Corporation Information
6.18.2 Unichem Laboratories Montelukast Drug Description and Business Overview
6.18.3 Unichem Laboratories Montelukast Drug Sales, Revenue and Gross Margin (2018-2024)
6.18.4 Unichem Laboratories Montelukast Drug Product Portfolio
6.18.5 Unichem Laboratories Recent Developments/Updates
6.19 Amneal Pharmaceuticals
6.19.1 Amneal Pharmaceuticals Corporation Information
6.19.2 Amneal Pharmaceuticals Montelukast Drug Description and Business Overview
6.19.3 Amneal Pharmaceuticals Montelukast Drug Sales, Revenue and Gross Margin (2018-2024)
6.19.4 Amneal Pharmaceuticals Montelukast Drug Product Portfolio
6.19.5 Amneal Pharmaceuticals Recent Developments/Updates
6.20 Shanghai Anbison Lab
6.20.1 Shanghai Anbison Lab Corporation Information
6.20.2 Shanghai Anbison Lab Montelukast Drug Description and Business Overview
6.20.3 Shanghai Anbison Lab Montelukast Drug Sales, Revenue and Gross Margin (2018-2024)
6.20.4 Shanghai Anbison Lab Montelukast Drug Product Portfolio
6.20.5 Shanghai Anbison Lab Recent Developments/Updates
6.21 Perrigo
6.21.1 Perrigo Corporation Information
6.21.2 Perrigo Montelukast Drug Description and Business Overview
6.21.3 Perrigo Montelukast Drug Sales, Revenue and Gross Margin (2018-2024)
6.21.4 Perrigo Montelukast Drug Product Portfolio
6.21.5 Perrigo Recent Developments/Updates
6.22 Cipla
6.22.1 Cipla Corporation Information
6.22.2 Cipla Montelukast Drug Description and Business Overview
6.22.3 Cipla Montelukast Drug Sales, Revenue and Gross Margin (2018-2024)
6.22.4 Cipla Montelukast Drug Product Portfolio
6.22.5 Cipla Recent Developments/Updates
6.23 CSPC Ouyi Pharmaceutical
6.23.1 CSPC Ouyi Pharmaceutical Corporation Information
6.23.2 CSPC Ouyi Pharmaceutical Montelukast Drug Description and Business Overview
6.23.3 CSPC Ouyi Pharmaceutical Montelukast Drug Sales, Revenue and Gross Margin (2018-2024)
6.23.4 CSPC Ouyi Pharmaceutical Montelukast Drug Product Portfolio
6.23.5 CSPC Ouyi Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Montelukast Drug Industry Chain Analysis
7.2 Montelukast Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Montelukast Drug Production Mode & Process
7.4 Montelukast Drug Sales and Marketing
7.4.1 Montelukast Drug Sales Channels
7.4.2 Montelukast Drug Distributors
7.5 Montelukast Drug Customers
8 Montelukast Drug Market Dynamics
8.1 Montelukast Drug Industry Trends
8.2 Montelukast Drug Market Drivers
8.3 Montelukast Drug Market Challenges
8.4 Montelukast Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Montelukast Drug Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Montelukast Drug Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Montelukast Drug Market Competitive Situation by Manufacturers in 2022
Table 4. Global Montelukast Drug Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Montelukast Drug Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Montelukast Drug Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Montelukast Drug Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Montelukast Drug Average Price (USD/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Montelukast Drug, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Montelukast Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Montelukast Drug, Product Type & Application
Table 12. Global Key Manufacturers of Montelukast Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Montelukast Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Montelukast Drug as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Montelukast Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Montelukast Drug Sales by Region (2018-2024) & (K Units)
Table 18. Global Montelukast Drug Sales Market Share by Region (2018-2024)
Table 19. Global Montelukast Drug Sales by Region (2024-2029) & (K Units)
Table 20. Global Montelukast Drug Sales Market Share by Region (2024-2029)
Table 21. Global Montelukast Drug Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Montelukast Drug Revenue Market Share by Region (2018-2024)
Table 23. Global Montelukast Drug Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Montelukast Drug Revenue Market Share by Region (2024-2029)
Table 25. North America Montelukast Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Montelukast Drug Sales by Country (2018-2024) & (K Units)
Table 27. North America Montelukast Drug Sales by Country (2024-2029) & (K Units)
Table 28. North America Montelukast Drug Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Montelukast Drug Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Montelukast Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Montelukast Drug Sales by Country (2018-2024) & (K Units)
Table 32. Europe Montelukast Drug Sales by Country (2024-2029) & (K Units)
Table 33. Europe Montelukast Drug Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Montelukast Drug Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Montelukast Drug Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Montelukast Drug Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Montelukast Drug Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Montelukast Drug Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Montelukast Drug Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Montelukast Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Montelukast Drug Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Montelukast Drug Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Montelukast Drug Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Montelukast Drug Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Montelukast Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Montelukast Drug Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Montelukast Drug Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Montelukast Drug Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Montelukast Drug Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Montelukast Drug Sales (K Units) by Type (2018-2024)
Table 51. Global Montelukast Drug Sales (K Units) by Type (2024-2029)
Table 52. Global Montelukast Drug Sales Market Share by Type (2018-2024)
Table 53. Global Montelukast Drug Sales Market Share by Type (2024-2029)
Table 54. Global Montelukast Drug Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Montelukast Drug Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Montelukast Drug Revenue Market Share by Type (2018-2024)
Table 57. Global Montelukast Drug Revenue Market Share by Type (2024-2029)
Table 58. Global Montelukast Drug Price (USD/Unit) by Type (2018-2024)
Table 59. Global Montelukast Drug Price (USD/Unit) by Type (2024-2029)
Table 60. Global Montelukast Drug Sales (K Units) by Application (2018-2024)
Table 61. Global Montelukast Drug Sales (K Units) by Application (2024-2029)
Table 62. Global Montelukast Drug Sales Market Share by Application (2018-2024)
Table 63. Global Montelukast Drug Sales Market Share by Application (2024-2029)
Table 64. Global Montelukast Drug Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Montelukast Drug Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Montelukast Drug Revenue Market Share by Application (2018-2024)
Table 67. Global Montelukast Drug Revenue Market Share by Application (2024-2029)
Table 68. Global Montelukast Drug Price (USD/Unit) by Application (2018-2024)
Table 69. Global Montelukast Drug Price (USD/Unit) by Application (2024-2029)
Table 70. Merck & Co. Corporation Information
Table 71. Merck & Co. Description and Business Overview
Table 72. Merck & Co. Montelukast Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 73. Merck & Co. Montelukast Drug Product
Table 74. Merck & Co. Recent Developments/Updates
Table 75. Teva Corporation Information
Table 76. Teva Description and Business Overview
Table 77. Teva Montelukast Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 78. Teva Montelukast Drug Product
Table 79. Teva Recent Developments/Updates
Table 80. Mylan Corporation Information
Table 81. Mylan Description and Business Overview
Table 82. Mylan Montelukast Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 83. Mylan Montelukast Drug Product
Table 84. Mylan Recent Developments/Updates
Table 85. Glenmark Pharmaceuticals Corporation Information
Table 86. Glenmark Pharmaceuticals Description and Business Overview
Table 87. Glenmark Pharmaceuticals Montelukast Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 88. Glenmark Pharmaceuticals Montelukast Drug Product
Table 89. Glenmark Pharmaceuticals Recent Developments/Updates
Table 90. Hikma Group Corporation Information
Table 91. Hikma Group Description and Business Overview
Table 92. Hikma Group Montelukast Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 93. Hikma Group Montelukast Drug Product
Table 94. Hikma Group Recent Developments/Updates
Table 95. Sandoz Corporation Information
Table 96. Sandoz Description and Business Overview
Table 97. Sandoz Montelukast Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 98. Sandoz Montelukast Drug Product
Table 99. Sandoz Recent Developments/Updates
Table 100. Torrent Pharmaceuticals Corporation Information
Table 101. Torrent Pharmaceuticals Description and Business Overview
Table 102. Torrent Pharmaceuticals Montelukast Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 103. Torrent Pharmaceuticals Montelukast Drug Product
Table 104. Torrent Pharmaceuticals Recent Developments/Updates
Table 105. Lannett Company Corporation Information
Table 106. Lannett Company Description and Business Overview
Table 107. Lannett Company Montelukast Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 108. Lannett Company Montelukast Drug Product
Table 109. Lannett Company Recent Developments/Updates
Table 110. Apotex Corporation Information
Table 111. Apotex Description and Business Overview
Table 112. Apotex Montelukast Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 113. Apotex Montelukast Drug Product
Table 114. Apotex Recent Developments/Updates
Table 115. Dr. Reddys Laboratories Corporation Information
Table 116. Dr. Reddys Laboratories Description and Business Overview
Table 117. Dr. Reddys Laboratories Montelukast Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 118. Dr. Reddys Laboratories Montelukast Drug Product
Table 119. Dr. Reddys Laboratories Recent Developments/Updates
Table 120. Aurobindo Pharma Corporation Information
Table 121. Aurobindo Pharma Description and Business Overview
Table 122. Aurobindo Pharma Montelukast Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 123. Aurobindo Pharma Montelukast Drug Product
Table 124. Aurobindo Pharma Recent Developments/Updates
Table 125. Accord Healthcare Corporation Information
Table 126. Accord Healthcare Description and Business Overview
Table 127. Accord Healthcare Montelukast Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 128. Accord Healthcare Montelukast Drug Product
Table 129. Accord Healthcare Recent Developments/Updates
Table 130. Hetero Corporation Information
Table 131. Hetero Description and Business Overview
Table 132. Hetero Montelukast Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 133. Hetero Montelukast Drug Product
Table 134. Hetero Recent Developments/Updates
Table 135. Unimark Corporation Information
Table 136. Unimark Description and Business Overview
Table 137. Unimark Montelukast Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 138. Unimark Montelukast Drug Product
Table 139. Unimark Recent Developments/Updates
Table 140. Ajanta Pharma Corporation Information
Table 141. Ajanta Pharma Description and Business Overview
Table 142. Ajanta Pharma Montelukast Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 143. Ajanta Pharma Montelukast Drug Product
Table 144. Ajanta Pharma Recent Developments/Updates
Table 145. MACLEODS Corporation Information
Table 146. MACLEODS Description and Business Overview
Table 147. MACLEODS Montelukast Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 148. MACLEODS Montelukast Drug Product
Table 149. MACLEODS Recent Developments/Updates
Table 150. Jubilant Pharma Corporation Information
Table 151. Jubilant Pharma Description and Business Overview
Table 152. Jubilant Pharma Montelukast Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 153. Jubilant Pharma Montelukast Drug Product
Table 154. Jubilant Pharma Recent Developments/Updates
Table 155. Unichem Laboratories Corporation Information
Table 156. Unichem Laboratories Description and Business Overview
Table 157. Unichem Laboratories Montelukast Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 158. Unichem Laboratories Montelukast Drug Product
Table 159. Unichem Laboratories Recent Developments/Updates
Table 160. Amneal Pharmaceuticals Corporation Information
Table 161. Amneal Pharmaceuticals Description and Business Overview
Table 162. Amneal Pharmaceuticals Montelukast Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 163. Amneal Pharmaceuticals Montelukast Drug Product
Table 164. Amneal Pharmaceuticals Recent Developments/Updates
Table 165. Shanghai Anbison Lab Corporation Information
Table 166. Shanghai Anbison Lab Description and Business Overview
Table 167. Shanghai Anbison Lab Montelukast Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 168. Shanghai Anbison Lab Montelukast Drug Product
Table 169. Shanghai Anbison Lab Recent Developments/Updates
Table 170. Perrigo Corporation Information
Table 171. Perrigo Description and Business Overview
Table 172. Perrigo Montelukast Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 173. Perrigo Montelukast Drug Product
Table 174. Perrigo Recent Developments/Updates
Table 175. Cipla Corporation Information
Table 176. Cipla Description and Business Overview
Table 177. Cipla Montelukast Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 178. Cipla Montelukast Drug Product
Table 179. Cipla Recent Developments/Updates
Table 180. CSPC Ouyi Pharmaceutical Corporation Information
Table 181. CSPC Ouyi Pharmaceutical Description and Business Overview
Table 182. CSPC Ouyi Pharmaceutical Montelukast Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 183. CSPC Ouyi Pharmaceutical Montelukast Drug Product
Table 184. CSPC Ouyi Pharmaceutical Recent Developments/Updates
Table 185. Key Raw Materials Lists
Table 186. Raw Materials Key Suppliers Lists
Table 187. Montelukast Drug Distributors List
Table 188. Montelukast Drug Customers List
Table 189. Montelukast Drug Market Trends
Table 190. Montelukast Drug Market Drivers
Table 191. Montelukast Drug Market Challenges
Table 192. Montelukast Drug Market Restraints
Table 193. Research Programs/Design for This Report
Table 194. Key Data Information from Secondary Sources
Table 195. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Montelukast Drug
Figure 2. Global Montelukast Drug Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Montelukast Drug Market Share by Type in 2022 & 2029
Figure 4. Tablets Product Picture
Figure 5. Oral Granules Product Picture
Figure 6. Global Montelukast Drug Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Montelukast Drug Market Share by Application in 2022 & 2029
Figure 8. Hospital
Figure 9. Drug Store
Figure 10. Others
Figure 11. Global Montelukast Drug Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Montelukast Drug Market Size (2018-2029) & (US$ Million)
Figure 13. Global Montelukast Drug Sales (2018-2029) & (K Units)
Figure 14. Global Montelukast Drug Average Price (USD/Unit) & (2018-2029)
Figure 15. Montelukast Drug Report Years Considered
Figure 16. Montelukast Drug Sales Share by Manufacturers in 2022
Figure 17. Global Montelukast Drug Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Montelukast Drug Players: Market Share by Revenue in 2022
Figure 19. Montelukast Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Montelukast Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Montelukast Drug Sales Market Share by Country (2018-2029)
Figure 22. North America Montelukast Drug Revenue Market Share by Country (2018-2029)
Figure 23. U.S. Montelukast Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Montelukast Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Montelukast Drug Sales Market Share by Country (2018-2029)
Figure 26. Europe Montelukast Drug Revenue Market Share by Country (2018-2029)
Figure 27. Germany Montelukast Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Montelukast Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Montelukast Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Montelukast Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Montelukast Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Montelukast Drug Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Montelukast Drug Revenue Market Share by Region (2018-2029)
Figure 34. China Montelukast Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Montelukast Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Montelukast Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Montelukast Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Montelukast Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Taiwan Montelukast Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Indonesia Montelukast Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Thailand Montelukast Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Malaysia Montelukast Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Philippines Montelukast Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Latin America Montelukast Drug Sales Market Share by Country (2018-2029)
Figure 45. Latin America Montelukast Drug Revenue Market Share by Country (2018-2029)
Figure 46. Mexico Montelukast Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Brazil Montelukast Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Argentina Montelukast Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa Montelukast Drug Sales Market Share by Country (2018-2029)
Figure 50. Middle East & Africa Montelukast Drug Revenue Market Share by Country (2018-2029)
Figure 51. Turkey Montelukast Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia Montelukast Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. UAE Montelukast Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Global Sales Market Share of Montelukast Drug by Type (2018-2029)
Figure 55. Global Revenue Market Share of Montelukast Drug by Type (2018-2029)
Figure 56. Global Montelukast Drug Price (USD/Unit) by Type (2018-2029)
Figure 57. Global Sales Market Share of Montelukast Drug by Application (2018-2029)
Figure 58. Global Revenue Market Share of Montelukast Drug by Application (2018-2029)
Figure 59. Global Montelukast Drug Price (USD/Unit) by Application (2018-2029)
Figure 60. Montelukast Drug Value Chain
Figure 61. Montelukast Drug Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed